Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total Therapy Study XVI for ALL
NCT00549848Phase 3Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Oct 2007
- Primary completion
- Sep 2020
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by St. Jude Children's Research Hospital. Started Oct 2007; status: completed.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00549848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549848.